Pratigya G.
About Pratigya G.
Pratigya G. serves as the Associate Director at Mirum Pharmaceuticals, where she has worked since 2020. She has a robust academic background in biomedical sciences and extensive experience in managing global oncology clinical trials.
Work at Mirum Pharmaceuticals
Pratigya G. has been serving as Associate Director at Mirum Pharmaceuticals since 2020. In this role, she is responsible for overseeing various aspects of clinical development, particularly in oncology. Her experience includes managing global clinical trials, where she applies her expertise in strategic planning and site management. Pratigya's role at Mirum Pharmaceuticals highlights her commitment to advancing clinical research and ensuring regulatory compliance.
Education and Expertise
Pratigya G. holds a Doctor of Philosophy (PhD) in Immunology from Cardiff University, where she studied from 2007 to 2011. She also completed Post Doctoral Training at the University of Cambridge, focusing on Lentiviral Gene Therapy for Type 1 Diabetes, from 2011 to 2014. Prior to her doctoral studies, she earned a Bachelor of Science (BSc) in Biomedical Sciences from the University of Durham from 2004 to 2007. Her educational background provides a solid foundation for her expertise in clinical research and regulatory compliance.
Background
Pratigya G. has a diverse professional background in clinical research. She began her career as a PhD student at Cardiff University, followed by a role as a Postdoctoral Research Associate at the University of Cambridge. After her postdoctoral training, she worked as a Clinical Study Manager at The Micron Group from 2014 to 2017 and later as a Global Clinical Trial Manager at CytomX Therapeutics from 2018 to 2020. This progression reflects her growing responsibilities in managing clinical trials and collaborations.
Achievements
Pratigya G. has a proven track record in managing global oncology clinical trials, demonstrating her ability to oversee strategic planning and site management effectively. She possesses a strong understanding of Good Clinical Practice (GCP) and FDA regulations, which ensures regulatory compliance in clinical studies. Her experience in fostering successful collaborations both internally and externally further underscores her contributions to the field of clinical research.